• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

OHUE YOSHIHIRO  大植 祥弘

Researcher Number 70435014
Other IDs
  • ORCIDhttps://orcid.org/0000-0003-0171-8367
Affiliation (based on the past Project Information) *help 2018 – 2019: 国立研究開発法人国立がん研究センター, 先端医療開発センター, ユニット長
2014 – 2017: 川崎医科大学, 医学部, 講師
Review Section/Research Field
Principal Investigator
Tumor therapeutics / Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Tumor biology
Keywords
Principal Investigator
がん抗原 / 肺がん / 腫瘍免疫 / がん免疫 / 肺癌 / ネオ抗原 / T細胞 / 免疫活性化 / 癌 / 免疫チェックポイント … More / Galectin-9 / TIM-3 / PD-1 / XAGE1 / 免疫チェックポイント分子 / 免疫療法 / 予後 / 免疫 / 抗体 / がん精巣抗原 … More
Except Principal Investigator
肺がん / 非小細胞肺癌 / 腫瘍浸潤リンパ球 / TIM-3 / PD-1 / PD-L1 / Treg / 制御性T細胞 / 肺癌微小環境 Less
  • Research Projects

    (4 results)
  • Research Products

    (39 results)
  • Co-Researchers

    (7 People)
  •  XAGE1免疫と新生抗原免疫を指標とした肺がん免疫療法の効果予測診断法の特許開発Principal Investigator

    • Principal Investigator
      大植 祥弘
    • Project Period (FY)
      2018 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      National Cancer Center Japan
  •  Identification of immunosuppressive factor in tumor microenvironment in patient with lung cancerPrincipal Investigator

    • Principal Investigator
      Ohue Yoshihiro
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kawasaki Medical School
  •  Identification of tumor microenvironment involving tumor infiltrating regulatory T cells in lung cancer

    • Principal Investigator
      Kurose Koji
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor biology
    • Research Institution
      Kawasaki Medical School
  •  Clinical development of the next-generation cancer immunotherapy against lung adenocarcinomaPrincipal Investigator

    • Principal Investigator
      OHUE YOSHIHIRO
    • Project Period (FY)
      2014 – 2015
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kawasaki Medical School

All 2019 2018 2017 2016 2015 2014 Other

All Journal Article Presentation Book Patent

  • [Book] 特集 肺癌免疫療法の新たな展開 免疫チェックポイントの役割とその阻害2016

    • Author(s)
      岡三喜男, 大植祥弘
    • Total Pages
      115
    • Publisher
      日本胸部臨床
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Book] 日本において保険承認されたがん免疫療法のリアル-非小細胞肺がん2016

    • Author(s)
      大植祥弘
    • Total Pages
      234
    • Publisher
      Cancer Board Square
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Journal Article] Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti?Programmed Cell Death-1 Therapy in NSCLC2019

    • Author(s)
      Ohue Yoshihiro、Kurose Koji、Karasaki Takahiro、Isobe Midori、Yamaoka Takaaki、Futami Junichiro、Irei Isao、Masuda Takeshi、Fukuda Masaaki、Kinoshita Akitoshi、Matsushita Hirokazu、Shimizu Katsuhiko、Nakata Masao、Hattori Noboru、Yamaguchi Hiroyuki、Fukuda Minoru、Nozawa Ryohei、Kakimi Kazuhiro、Oka Mikio
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 14 Issue: 12 Pages: 2071-2083

    • DOI

      10.1016/j.jtho.2019.08.008

    • NAID

      120006796543

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K15226, KAKENHI-PROJECT-18H02696, KAKENHI-PROJECT-19H03528, KAKENHI-PROJECT-19H03729, KAKENHI-PROJECT-17K10778, KAKENHI-PROJECT-18K07306
  • [Journal Article] NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC2017

    • Author(s)
      Takeoka T, Nagase H, Kurose K, Ohue Y, Yamasaki M, Takiguchi S, Sato E, Isobe M, Kanazawa T, Matsumoto M, Iwahori K, Kawashima A, Morimoto-Okazawa A, Nishikawa H, Oka M, Pan L, Venhaus R, Nakayama E, Mori M, Doki Y, Wada H.
    • Journal Title

      J Immunother

      Volume: epub Issue: 4 Pages: 140-147

    • DOI

      10.1097/cji.0000000000000162

    • Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-16K21533, KAKENHI-PROJECT-16K15551, KAKENHI-PROJECT-17H06162
  • [Journal Article] Possible role of IL-25 in eosinophilic lung inflammation in patients with chronic eosinophilic pneumonia.2017

    • Author(s)
      Katoh S, Ikeda M, Matsumoto N, Shimizu H, Abe M, Ohue Y, Mouri K, Nakazato M, Oka M.
    • Journal Title

      Lung

      Volume: 195 Issue: 6 Pages: 707-712

    • DOI

      10.1007/s00408-017-0048-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-16K18463
  • [Journal Article] Biomarkers for differentiation of patients with asthma and chronic obstractive pulmonary disease.2017

    • Author(s)
      Katoh S, Ikeda M, Shirai R, Abe M, Ohue Y, Kobashi Y, Oka M.
    • Journal Title

      Journal of Asthma

      Volume: 16 Issue: 10 Pages: 1-7

    • DOI

      10.1080/02770903.2017.1391281

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-16K18463
  • [Journal Article] Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.2016

    • Author(s)
      Ogawara D, Fukuda M, Ueno S, Ohue Y, Takemoto S, Mizoguchi K, Nakatomi K, Nakamura Y, Obase Y, Honda T, Tsukamoto K, Ashizawa K, Oka M, Kohno S.
    • Journal Title

      Supportive Care in Cancer

      Volume: 2 Pages: 615-619

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Journal Article] Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.2016

    • Author(s)
      Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E
    • Journal Title

      Cancer Immunology Research

      Volume: 4 Pages: 1049-1060

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Journal Article] Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells2016

    • Author(s)
      Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E.
    • Journal Title

      Cancer Immunol Res

      Volume: 12 Pages: 1049-1060

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Journal Article] Increase of activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an anti-human CCR4 mAb (KM2760).2015

    • Author(s)
      Koji Kurose, Yoshihiro Ohue, Eiichi Sato Akira Yamauchi, Shingo Eikawa, Midori Isobe, Yumi Nishio, Akiko Uenaka, Mikio Oka, and Eiichi Nakayama.
    • Journal Title

      J Thorac Oncol.

      Volume: 10 Issue: 1 Pages: 74-83

    • DOI

      10.1097/jto.0000000000000364

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24591473, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-26830117
  • [Journal Article] Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.2015

    • Author(s)
      2.Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R, Nakayama E.
    • Journal Title

      Clin Cancer Res.

      Volume: 21 Issue: 19 Pages: 4327-36

    • DOI

      10.1158/1078-0432.ccr-15-0357

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-15K14403, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-26670237, KAKENHI-PROJECT-26670581, KAKENHI-PROJECT-26830117, KAKENHI-PROJECT-25290058, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-26290056
  • [Journal Article] Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.2015

    • Author(s)
      Katoh S, Ikeda M, Shimizu H, Abe M, Ohue Y, Mouri K, Kobashi Y, Oka M.
    • Journal Title

      Lung

      Volume: 5 Issue: 5 Pages: 683-689

    • DOI

      10.1007/s00408-015-9775-x

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Journal Article] Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients2014

    • Author(s)
      Yoshihiro Ohue, Hisashi Wada, Mikio Oka & Eiichi Nakayama
    • Journal Title

      Oncoimmunology

      Volume: e970032 Issue: 11 Pages: e970032-e970032

    • DOI

      10.4161/21624011.2014.970032

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Journal Article] Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody.2014

    • Author(s)
      Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, Fukuda M, Uenaka A, Oka M and Nakayama E.
    • Journal Title

      Clin. Cancer Res.

      Volume: 20 (19) Issue: 19 Pages: 5052-5063

    • DOI

      10.1158/1078-0432.ccr-14-0742

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-26830117
  • [Patent] 免疫因子を指標とした肺腺癌の予後演算式作成方法と予後推定方法2015

    • Inventor(s)
      大植祥弘、黒瀬浩史、岡三喜男、中山睿一
    • Industrial Property Rights Holder
      大植祥弘、黒瀬浩史、岡三喜男、中山睿一
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2015-212393
    • Filing Date
      2015-10-28
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] Serum NY-ESO-1 and XAGE1 Antibodies as Predictive Biomarkers in Anti-PD-1 Therapy for Non-Small-Cell Lung Cancer2019

    • Author(s)
      Oka M, Ohue Y, Kurose K, Karasaki T, Masuda T, Fukuda Ma, Kinoshita A, Shimizu K, Nakata M, Hattori N, Kakimi K, Yamaguchi H, Fukuda M
    • Organizer
      2019 ASCO-SITC Clinical Immuno-Oncology Symposium
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07306
  • [Presentation] Analysis of immunological resistance to anti - tumor immunity2019

    • Author(s)
      Yoshihiro Ohue
    • Organizer
      34 th EDRN Steering Committee Meeting
    • Invited
    • Data Source
      KAKENHI-PROJECT-18K07306
  • [Presentation] Serum NY-ESO-1 and XAGE1 antibodies as predictive biomarkers in anti-PD-1 therapy for non-small-cell lung cancer.2019

    • Author(s)
      Oka M, Ohue Y, Kurose K, Karasaki T, Isobe M, Yamaoka T, Futami J, Irei I, Masuda T, Fukuda M, Kinoshita A, Matsushita H, Shimizu K, Nakata M, Hattori N, Yamaguchi H, Fukuda M, Nozawa R, Kakimi K.
    • Organizer
      ASCO-SITC
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07306
  • [Presentation] Serum antibody against NY-ESO-1 and XAGE1 predicts clinical responses to anti-PD-1 therapy in non-small-cell lung cancer.2018

    • Author(s)
      Kurose K, Ohue Y, Karasaki T, Futami J, Irei I, Masuda T, Fukuda Ma, Kinoshita A, Matsushita H, Shimizu K, Yamaguchi H, Fukuda Mi, Kakimi K, Oka M.
    • Organizer
      Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07306
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients2018

    • Author(s)
      黒瀬 浩史, 大植 祥弘, 磯辺 みどり, 鈴木 進, 和田 尚, 上田 龍三, 中山 睿一, 岡 三喜男
    • Organizer
      第15回日本免疫治療学研究会学術集会
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients2017

    • Author(s)
      Kurose K, Ohue Y, Isobe M, Suzuki S, Wada H, Oka M, Ueda R, Nakayama E.
    • Organizer
      Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Presentation] Reviving chemotherapy sensitivity after anti-CCR4 mAb (mogamulizumab) treatment in lung cancer patients2017

    • Author(s)
      Koji Kurose, Yoshihiro Ohue, Midori Isobe, Susumu Suzuki, Hisashi Wada, Ryuzo Ueda, Eiichi Nakayama and Mikio Oka
    • Organizer
      IASLC 18th world conference on lung cancer(WCLC 2017)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K21533
  • [Presentation] 肺腺癌のTIM-3/Galectin-9経路を介した免疫抑制2017

    • Author(s)
      大植祥弘
    • Organizer
      第14回日本免疫治療学研究会学術集会
    • Place of Presentation
      東京大学(東京)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Correlation of Clinical Response and XAGE1 Immunity in Lung Adenocarcinoma.2017

    • Author(s)
      Ohue Y, Kurose K, Isobe M, Fukuda M, Nakayama E, Oka M
    • Organizer
      IASLC 18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Reviving Chemotherapy Sensityvity after Anti-CCR4 mAb (Mogamulizumab) Treatment in Lung Cancer Patients.2017

    • Author(s)
      Kurose K, Ohue Y, Isobe M, Suzuki S, Wada H, Ueda R, Nakayama E, Oka M.
    • Organizer
      IASLC 18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Immuno-inhibitory pathway, TIM-3/Galectin-9, in lung adenocarcinoma: clinical and in vitro analysis.2017

    • Author(s)
      Oka M, Ohue Y, Kurose K, Nishio Y, Isobe M, Nakayama E.
    • Organizer
      101st Annual Meeting of American Association of Cancer Research
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] 肺腺癌のTIM-3/Galectin-9経路を介した免疫抑制と予後の関連2016

    • Author(s)
      大植祥弘, 黒瀬浩史, 磯辺みどり, 西尾祐美, 岡三喜男, 中山睿一
    • Organizer
      第20回日本がん免疫学会総会
    • Place of Presentation
      大阪国際交流センター(大阪)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] 腫瘍PD-L1,Gal-9,XAGE1発現及びT細胞浸潤を指標とした肺腺癌の予後予測2016

    • Author(s)
      大植祥弘, 黒瀬浩史, 西尾祐美, 磯辺みどり, 福岡順也, 中山睿一, 岡三喜男
    • Organizer
      第56回日本呼吸器学会学術講演会
    • Place of Presentation
      京都国際会館(京都)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Role of TIM-3/Galectin-9 pathway in lung adenocarcinoma2016

    • Author(s)
      Ohue Y, Kurose K, Nishio Y, Isobe M, Oka M and Nakayama E.
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] Role of TIM-3/Galectin-9 pathway in lung adenocarcinoma2016

    • Author(s)
      Ohue Y, Kurose K, Nishio Y, Isobe M, Oka M and Nakayama E.
    • Organizer
      CRI-CIMT-EATI-AACR Second International Cancer Immunotherapy Conference
    • Place of Presentation
      ニューヨーク(アメリカ)
    • Data Source
      KAKENHI-PROJECT-16K18463
  • [Presentation] 肺腺癌でXAGE1に対する宿主免疫応答の解析と予後延長効果の証明2015

    • Author(s)
      Yoshihiro Ohue, Koji Kurose, Yumi Nishio, Midori Isobe, Akiko Uenaka, Mikio Oka and Eiichi Nakayama
    • Organizer
      第112回日本内科学会講演会
    • Place of Presentation
      みやこめっせ(京都)
    • Year and Date
      2015-04-10
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] Clinical effect of XAGE1(GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma2015

    • Author(s)
      Yoshihiro Ohue, Koji Kurose, Yumi Nishio, Midori Isobe, Akiko Uenaka, Mikio Oka and Eiichi Nakayama
    • Organizer
      第55回日本呼吸器学会学術講演会
    • Place of Presentation
      東京国際フォーラム(東京)
    • Year and Date
      2015-04-17
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] 進行期肺腺癌におけるXAGE1(GAGED2a)免疫と予後2015

    • Author(s)
      大植祥弘
    • Organizer
      第12回日本免疫治療学研究会学術集会
    • Place of Presentation
      東京ガーデンパレス(東京都)
    • Year and Date
      2015-02-28
    • Invited
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] Discriminant function for predicting survival of lung adenocarcinoma patients developed by using immune parameters of PD-L1,Gal-9, and XAGE1 expression on tumor cells and T cell infiltration score2015

    • Author(s)
      Yoshihiro Ohue, Koji Kurose, Yumi Nishio, Midori Isobe, Akiko Uenaka, Mikio Oka and Eiichi Nakayama
    • Organizer
      The Inaugural International Cancer Immunotherapy Conference
    • Place of Presentation
      New York(米国)
    • Year and Date
      2015-09-16
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] Survival prediciting discriminant function with immune parameters for lung adenocarcinoma patients2015

    • Author(s)
      Yoshihiro Ohue, Koji Kurose, Yumi Nishio, Midori Isobe, Akiko Uenaka, Mikio Oka and Eiichi Nakayama
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] 非小細胞肺がん患者で、免疫グロブリンγ鎖およびκ鎖の遺伝的変異がXAGE1免疫に及ぼす影響

    • Author(s)
      大植祥弘
    • Organizer
      第55回日本肺癌学会学術集会
    • Place of Presentation
      国立京都国際会館(京都府)
    • Year and Date
      2014-11-14 – 2014-11-16
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] Clinical effect of XAGE1 (GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma

    • Author(s)
      大植祥弘
    • Organizer
      22nd Annual International Cancer Immunotherapy Symposium
    • Place of Presentation
      The Grand Hyatt New York(N.Y. USA)
    • Year and Date
      2014-10-06 – 2014-10-08
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] 肺腺癌でXAGE1に対する宿主免疫応答の解析と予後延長効果の証明

    • Author(s)
      大植祥弘
    • Organizer
      第112回日本内科学会講演会
    • Place of Presentation
      みやこめっせ(京都府)
    • Year and Date
      2015-04-10 – 2015-04-12
    • Data Source
      KAKENHI-PROJECT-26830117
  • [Presentation] Clinical effect of XAGE1(GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma

    • Author(s)
      大植祥弘
    • Organizer
      第55回日本呼吸器学会学術講演会
    • Place of Presentation
      東京国際フォーラム(東京都)
    • Year and Date
      2015-04-17 – 2015-04-19
    • Data Source
      KAKENHI-PROJECT-26830117
  • 1.  Oka MIKIO (40223995)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 16 results
  • 2.  Kurose KOJI (30551139)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 14 results
  • 3.  Nakayama Eiichi (60180428)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 5 results
  • 4.  YAMAUCHI Mikako
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 5.  SUZUKI Susumu
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 6.  山内 明
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 7.  上田 龍三
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi